These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26373379)

  • 1. Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting.
    Fan L; Campagnoli S; Wu H; Grandi A; Parri M; De Camilli E; Grandi G; Viale G; Pileri P; Grifantini R; Song C; Jin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):103. PubMed ID: 26373379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
    Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
    J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions.
    Fan L; Yang Q; Tan J; Qiao Y; Wang Q; He J; Wu H; Zhang Y
    J Exp Clin Cancer Res; 2015 Sep; 34():106. PubMed ID: 26407971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    Li YF; Zhang HT; Xin L
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAT1: a potential target for monoclonal antibody therapy in colon cancer.
    Pileri P; Campagnoli S; Grandi A; Parri M; De Camilli E; Song C; Ganfini L; Lacombe A; Naldi I; Sarmientos P; Cinti C; Jin B; Grandi G; Viale G; Terracciano L; Grifantini R
    Br J Cancer; 2016 Jun; 115(1):40-51. PubMed ID: 27328312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
    Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
    Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug conjugated nanoparticles activated by cancer cell specific mRNA.
    Gossai NP; Naumann JA; Li NS; Zamora EA; Gordon DJ; Piccirilli JA; Gordon PM
    Oncotarget; 2016 Jun; 7(25):38243-38256. PubMed ID: 27203672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.
    Ma X; Hui H; Jin Y; Dong D; Liang X; Yang X; Tan K; Dai Z; Cheng Z; Tian J
    Biomaterials; 2016 May; 87():46-56. PubMed ID: 26897539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.
    Karmani L; Bouchat V; Bouzin C; Levêque P; Labar D; Bol A; Deumer G; Marega R; Bonifazi D; Haufroid V; Michiels C; Grégoire V; Feron O; Lucas S; Vander Borght T; Gallez B
    Nanomedicine (Lond); 2014 Sep; 9(13):1923-37. PubMed ID: 24547782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents.
    Fernandes AR; Jesus J; Martins P; Figueiredo S; Rosa D; Martins LM; Corvo ML; Carvalheiro MC; Costa PM; Baptista PV
    J Control Release; 2017 Jan; 245():52-61. PubMed ID: 27871990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of PEGylated polyethylenimine-entrapped gold nanoparticles for blood pool and tumor CT imaging.
    Zhou B; Zheng L; Peng C; Li D; Li J; Wen S; Shen M; Zhang G; Shi X
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):17190-9. PubMed ID: 25208617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells.
    Liu X; Huang N; Li H; Jin Q; Ji J
    Langmuir; 2013 Jul; 29(29):9138-48. PubMed ID: 23815604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy.
    Puvanakrishnan P; Park J; Chatterjee D; Krishnan S; Tunnell JW
    Int J Nanomedicine; 2012; 7():1251-8. PubMed ID: 22419872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary techniques (spICP-MS, TEM, and HPLC-ICP-MS) reveal the degradation of 40 nm citrate-stabilized Au nanoparticles in rat liver after intraperitoneal injection.
    Álvarez-Fernández García R; Fernández-Iglesias N; López-Chaves C; Sánchez-González C; Llopis J; Montes-Bayón M; Bettmer J
    J Trace Elem Med Biol; 2019 Sep; 55():1-5. PubMed ID: 31345346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
    Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
    Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice.
    Cai QY; Kim SH; Choi KS; Kim SY; Byun SJ; Kim KW; Park SH; Juhng SK; Yoon KH
    Invest Radiol; 2007 Dec; 42(12):797-806. PubMed ID: 18007151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
    Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
    J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
    Glazer ES; Zhu C; Massey KL; Thompson CS; Kaluarachchi WD; Hamir AN; Curley SA
    Clin Cancer Res; 2010 Dec; 16(23):5712-21. PubMed ID: 21138869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
    Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
    Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.